Chase Pharmaceuticals Corporation, based in Parsippany, NJ, focuses on the development of innovative therapies for neurological disorders, particularly Alzheimer's disease. The company specializes in advancing treatments that aim to improve cognitive function and overall quality of life for patients. With a commitment to addressing unmet medical needs, Chase Pharmaceuticals leverages cutting-edge research and technology to create effective solutions in the pharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

14 Patents

#31 in Parsippany, NJ

#843 in New Jersey

#22,319 in US

#42,249 in the World

Parsippany, NJ, United States of America

Chase Pharmaceuticals Corporation

Forward Citations = 85

2 inventors:

Thomas N Chase (14 out of 31 patents)

Kathleen E Clarence-Smith (14 out of 35 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Chase Pharmaceuticals Corporation. Retrieved from https://idiyas.com/company/chase-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]